Range
1.67 - 1.72
Vol / Avg.
502.4K/785.2K
Div / Yield
-
52 Wk
1.52 - 2.95
Mkt Cap
388.9M
Payout Ratio
-
Open
1.71
P/E
-
EPS
-0.05
Shares
227.4M
Outstanding
227.4M
Total Float
197.7M
Benzinga - 1 day ago
Benzinga - Jun 9, 2021, 9:22AM
Benzinga - May 5, 2021, 6:32AM
Benzinga - May 4, 2021, 4:43PM
Benzinga - Mar 4, 2021, 4:11PM
Benzinga - Feb 4, 2021, 9:27AM
Benzinga - Feb 4, 2021, 9:20AM
Benzinga - Feb 3, 2021, 4:08PM
Benzinga - Feb 3, 2021, 4:03PM
Benzinga - Feb 3, 2021, 8:17AM
Benzinga - Feb 2, 2021, 11:32AM
Benzinga - Feb 2, 2021, 9:43AM
Benzinga - Feb 2, 2021, 8:04AM
Benzinga - Jan 25, 2021, 8:33AM
Benzinga - Jan 4, 2021, 8:33AM
Benzinga - Dec 16, 2020, 8:58AM
Benzinga - Dec 16, 2020, 8:31AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-02
REV
Q1 2021Est.ActualSurprise
EPS-0.040-0.050 -0.0100
REV3.000M2.212M-788.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DRRXDurect0%388.9M

Durect Frequently Asked Questions

Q

How do I buy Durect (DRRX) stock?

A

You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Durect's (DRRX) competitors?

A

Other companies in Durect’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), BioDelivery Sciences Intl (NASDAQ:BDSI) and CymaBay Therapeutics (NASDAQ:CBAY).

Q

What is the target price for Durect (DRRX) stock?

A

The latest price target for Durect (NASDAQ: DRRX) was reported by HC Wainwright & Co. on May 5, 2021. The analyst firm set a price target for 6.00 expecting DRRX to rise to within 12 months (a possible 250.88% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Durect (DRRX)?

A

The stock price for Durect (NASDAQ: DRRX) is $1.71 last updated Today at 8:00:02 PM.

Q

Does Durect (DRRX) pay a dividend?

A

There are no upcoming dividends for Durect.

Q

When is Durect (NASDAQ:DRRX) reporting earnings?

A
Durect’s Q2 earnings are confirmed for after-market on August 2, 2021.
Q

Is Durect (DRRX) going to split?

A

There is no upcoming split for Durect.

Q

What sector and industry does Durect (DRRX) operate in?

A

Durect is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.